NCT00003716View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

Trial Locations (1)

94305-5408

Stanford University Medical Center, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00003716 - Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy | Biotech Hunter | Biotech Hunter